ABSTRACT
Abstract Objectives The aim of this study was to evaluate the impact of a bundle called FAST HUG in ventilator-associated pneumonia, weigh the healthcare costs of ventilator-associated pneumonia patients in the intensive care unit, and hospital mortality due to ventilator-associated pneumonia. Material and methods The study was performed in a private hospital that has an 8-bed intensive care unit. It was divided into two phases: before implementing FAST HUG, from August 2011 to August 2012 and after the implementation of FAST HUG, from September 2012 to December 2013. An individual form for each patient in the study was filled out by using information taken electronically from the hospital medical records. The following data was obtained from each patient: age, gender, reason for hospitalization, use of three or more antibiotics, length of stay, intubation time, and outcome. Results After the implementation of FAST HUG, there was an observable decrease in the occurrence of ventilator-associated pneumonia (p < 0.01), as well as a reduction in mortality rates (p < 0.01). In addition, the intervention resulted in a significant reduction in intensive care unit hospital costs (p < 0.05). Conclusion The implementation of FAST HUG reduced the number of ventilator-associated pneumonia cases. Thus, decreasing costs, reducing mortality rates and length of stay, which therefore resulted in an improvement to the overall quality of care.
Subject(s)
Humans , Male , Female , Aged , Infection Control/methods , Critical Care/methods , Pneumonia, Ventilator-Associated/prevention & control , Brazil/epidemiology , Clinical Protocols , Survival Rate , Hospital Mortality , Hospital Costs , APACHE , Pneumonia, Ventilator-Associated/economics , Pneumonia, Ventilator-Associated/mortality , Intensive Care Units , Anti-Bacterial Agents/therapeutic useABSTRACT
Os autores estudaram as variaçöes induzidas na pressäo arterial sistêmica e as modificaçöes promovidas na hemodinâmica e funçäo renais de 9 pacientes cirróticos com ascite, em tratamento convencional após uso oral de 25mg de captopril. Concluem que o sistema renina-angiotensina (SRA) näo é o principal determinante dos níveis pressóricos sistêmicos do grupo examinado e que a inibiçäo do SRA intra-renal reduz a filtraçäo glomerular e a quantidade excretada de sódio destes pacientes